.Merck defeats revenues requirements, raises purchases overview on solid requirement for best medications like Keytruda CNBCMerck & Co. (MRK US) Trumps Earnings Forecasts as Keytruda Sales Rise BloombergMerck Stock: Pharma Titan Posts Tough Results, But Expectation Tumbles Short Investor's Business DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats income as well as sales assumptions in the middle of Keytruda asset, but gives blended full-year outlook MarketWatch.